International Isotopes INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OQB
Radnostix Inc. announced the approval of its 2026 Incentive Plan and the election of five directors at its 2026 Annual Meeting of Shareholders.
OQB
Radnostix, Inc. has acquired the Lara System technology platform and Ellexa Explorer Software from Lucerno Dynamics, LLC for an initial purchase price of $900,000, comprising cash and stock, with potential for future milestone and earnout payments.
OQB
Radnostix Inc. has extended the maturity date of its Series C Convertible Redeemable Preferred Stock by one year to February 28, 2028, with all other terms remaining unchanged.
OQB
Radnostix, Inc. announced the mutual termination of its Asset Purchase Agreement for the DUF6 Plant and initiated a voluntary recall of certain Dibasic Sodium Phosphate Capsules.
OQB
International Isotopes Inc. has officially changed its corporate name to Radnostix, Inc., reflecting an expanded focus on healthcare-related radioisotopes and theranostics.
OQB
International Isotopes Inc. announced a new long-term employment agreement for its CEO, appointed a new director with nuclear pharmacy expertise, and updated its corporate bylaws to enhance governance.
OQB
International Isotopes Inc. announced a new long-term employment agreement for its CEO, appointed a new director with nuclear pharmacy expertise, and updated its corporate bylaws to enhance governance.
OQB
International Isotopes Inc. shareholders approved a reverse stock split, re-elected all four directors, and ratified the company's independent auditor at the 2025 Annual Meeting.
OQB
International Isotopes Inc. has extended the maturity date of its Series C Convertible Redeemable Preferred Stock by two years to February 28, 2027.
OQB
International Isotopes Inc. held its 2024 Annual Meeting where shareholders elected four directors and ratified Haynie & Company as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
OQB
International Isotopes Inc. has agreed to sell its depleted uranium deconversion and fluorine processing assets to American Fuel Resources for $12.5 million in cash.